GLP-1 RA Reduces Severity of Steatotic Liver Disease in People With HIV

MONDAY, March 18, 2024 -- For people with HIV (PWH) with metabolic-associated steatotic liver disease (MASLD), semaglutide is associated with absolute and relative declines in intrahepatic triglyceride (IHTG) content, according to a study presented...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news